专题:林清轩港股IPO:毛利率超82% 营销支出12倍于研发 本土美妆公司今年在资本市场备受热捧。 新一轮美妆行业上市潮正在涌动。 上海林清轩生物科技股份有限公司(以下简称“林清轩”)近日向港交所递表,拟在港股主板上市。 据公司招股书,2022年-2024年,公司总收入分别为人民币6.91亿元、8.05亿元和12.1亿元,复合年增长率达32.3%。2024年,公司净利润为人民币...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.